News

THURSDAY, May 15, 2025 (HealthDay News) -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and obesity ...
Cite this: Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans - Medscape - Sep 01, 2011. Abstract and Introduction Research Design and ...
People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
More information: Yael Wolff Sagy et al, Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective ...
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
Combining elements of four hormones into a single drug, researchers hope a next-generation weight loss drug will address not only obesity, but associated conditions like type 2 diabetes, cancer, and ...
They’ve all been used to describe effects of the rapid weight loss that can come from taking glucagon-like peptide-1 receptor agonists like semaglutide, which is in Ozempic.
The effect of glucagon-like peptide-1 receptor agonists on serum uric acid concentration: a systematic review and meta-analysis. Br J Clin Pharmacol 2022;88:3627-3637. Crossref ...
The researchers found that over a median of 7.5 years, ORC occurred in 5.62 cases per 1,000 person-years in the BMS group and in 5.89 cases per 1,000 person-years in the GLP-1 RA group (adjusted ...
Lower risks for anxiety disorders, substance use disorders, cognitive deficits seen for those undergoing metabolic and bariatric surgery ...